
SHANGHAI, Jan. 6 (UPI) -- An ingredient in birch bark may have an array of metabolic benefits, researchers in Shanghai say.
Researchers at Shanghai Institutes for Biological Sciences, led by Bao-Liang Song, found the compound -- betulin -- affected sterol regulatory element-binding proteins involved in the biosynthesis of cholesterol, fatty acids and triglycerides that are known as SREBPs.
"Our study shows that the SREBP pathway is a good target for several metabolic diseases," Song said in a statement.
The animal study, published in Cell Metabolism, found betulin helped lower cholesterol, prevent obesity, and improve insulin sensitivity in mice. The betulin-treated mice were also more resistant to developing atherosclerotic plaques in their arteries.
Song and colleagues gave betulin, the cholesterol-lowering statin lovastatin, or a placebo to mice fed a high-fat, Western diet, for six weeks. Compared to placebo, the researchers found both betulin and lovastatin led the mice to gain less weight on the high-fat diet, but by different means.
Betulin caused the animals to burn more calories while lovastatin seemed to reduce the amount of fat taken up from the diet, Song said.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, May 27 (UPI) --
President Obama has put U.S. foreign policy on auto-pilot while he concentrates on getting re-elected, a senior Republican senator said Sunday.
|
'Men in Black' leads U.S. box office ... Michelle Obama, daughters see Beyonce ... Lady Gaga cancels Jakarta gig for security ... Madonna asks for pool at Israel venue ... News from United Press International.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption